Abstract
Optically Pumped Magnetometer based Magnetoencephalography (OP-MEG) has significant potential for clinical use in pre-surgical planning in epilepsy. Unlike current clinical MEG, the sensors do not require cryogenic cooling and so can be placed directly on the patient’s head. This allows the patient to move during the recording and means that the sensor positions can be chosen to suit the patient’s head shape and suspected epileptogenic focus. However, OP-MEG is a new technology, and more work is needed to demonstrate this potential. We present OP-MEG recordings from a patient (male in their 30s) with a radiologically identifiable focal cortical dysplasia (FCD) in the right superior frontal sulcus approximately 1.9 cm3 in volume. Previous scalp EEG studies and prolonged video-EEG telemetry did not identify any interictal epileptiform abnormalities. We recorded 30 minutes of OP-MEG with 62-channel, whole-head sensor coverage. During the experiment, the patient’s head was unconstrained. We localised interictal epileptiform discharges (IEDs) from this recording with a beamformer and by fitting a dipole to the averaged IED data. Both the beamformer peak and dipole fit locations were within 2.3 cm of the MRI lesion boundary. This single subject, proof-of-concept recording provides further evidence that OP-MEG can be a useful and minimally invasive tool in the clinical evaluation of epilepsy.
Competing Interest Statement
This work was in part funded by a Wellcome collaborative award, which involves a collaborative agreement with the OPM manufacturer QuSpin.
Funding Statement
This work was supported by a Wellcome collaborative award to GRB, Matthew Brookes and Richard Bowtell (203257/Z/16/Z, 203257/B/16/Z), the EPSRC-funded UCL Centre for Doctoral Training in Medical Imaging (EP/L016478/1), the Department of Health's NIHR-funded Biomedical Research Centre at University College London Hospitals and EPSRC (EP/T001046/1) funding from the Quantum Technology hub in sensing and timing (sub-award QTPRF02). UV is funded by NIHR, Academy of Medical Sciences, Epilepsy Research UK, and MRC. NA and RAS are supported by a Wellcome Principal Research Fellowship to Eleanor Maguire (210567/Z/18/Z). The Wellcome Centre for Human Neuroimaging is supported by core funding from the Wellcome Trust (203147/Z/16/Z).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval for the study was granted by the Medicines and Healthcare products Regulatory Agency, and informed consent was obtained from the patient prior to participation.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Anonymized OP-MEG data would be available on reasonable request from the corresponding author.